Why the study?
Does grape seed procyanidin B2 protect against diabetic cardiomyopathy in db/db mice?
Does grape seed procyanidin B2 protect against diabetic cardiomyopathy in db/db mice?
Grape seed procyanidin B2 demonstrates protective effects against diabetic cardiomyopathy in a mouse model by regulating proteins involved in cardiac fibrosis and proliferation.
GSPB2 shows promise in murine diabetic cardiomyopathy; leaves open human translation pending clinical trials.
Diabetic cardiomyopathy is one of the major complications of diabetes mellitus. Oxidative stress appears to play a substantial role in cardiomyopathy. Grape seed procyanidin B2 (GSPB2) has been known as an anti-oxidant in treating diabetes mellitus; however, little is known about its effects and underlying mechanisms on diabetic cardiomyopathy. The present study is to explore the molecular targets of GSPB2 responsible for the anti-oxidative effects in db/db mice by quantitative proteomics. GSPB2 (30 mg/kg body weight/day) were intragastric administrated to db/db mice for 10 weeks. Proteomics of the heart tissue extracts by isobaric tags for relative and absolute quantification analysis was obtained from db/db mice. Our study provides important evidence that GSPB2 protect against cardiomyopathy in diabetes mellitus, which are believed to result from regulating the expression of key proteins involving cardiac fibrosis and proliferation. GSPB2 could be expected to become novel clinical application in fighting against diabetic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Luan et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: